TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
DWTX

Dogwood Therapeutics, Inc.

Healthcare · Biotechnology

1.40$ +0.0% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns Dogwood Therapeutics, Inc. (DWTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 17.1% of the shares are freely tradable; institutional investors hold 11.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 11.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 73.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 17.1%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 34Mio.

Largest Shareholders

Institutions

Institutions DWTX
Name Stake (%) Shares Change (%) Date
Armistice Capital, LLC 9.65 3,280,000 +0.0 03/31/2026
Millennium Management LLC 1.01 341,814 +0.0 06/30/2026
Vanguard Capital Management, LLC 0.39 132,154 +0.0 03/31/2026
Geode Capital Management, LLC 0.23 79,434 +373.4 03/31/2026
Vanguard Fiduciary Trust Co 0.18 62,736 +0.0 03/31/2026
Northern Trust Corp 0.07 23,779 +0.0 03/31/2026
The Goldman Sachs Group Inc 0.04 14,598 +0.0 03/31/2026

Funds

Funds DWTX
Name Stake (%) Shares Change (%) Date
Fidelity Extended Market Index 0.17 56,974 -0.2 07/31/2026
iShares Micro-Cap ETF 0.08 26,449 -1.9 08/31/2026
Fidelity Series Total Market Index 0.04 13,059 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?